Sort
326,823 grants matching “clinical trial”
HIV-1 Therapy with CCR5 mAB PRO 140-Overview
$3,028,502William C Olson · Progenics Pharmaceuticals, Inc. · U19 · FY2006 · AI
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder
$3,027,897Paul J Kenny · Eolas Therapeutics, Inc. · UH3 · FY2025 · DA
Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU
$3,027,841Daniel R Kuritzkes · Massachusetts General Hospital · U01 · FY2010 · AI
LC: HIV Prevention Trials Network
$3,027,715Susan H Eshleman · Johns Hopkins University · UM1 · FY2020 · AI
Women's Interagency HIV Study (WIHS) IV, Chicago Consortium
$3,026,718Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2009 · AI
Long-acting, self-administered HIV therapy with th CCR5 antibody PRO 140
$3,026,298Jeffrey M Jacobson · Drexel University · U01 · FY2011 · AI
COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDS
$3,026,291Social And Scientific Systems, Inc. · U01 · FY2000 · AI
Women's Interagency HIV Study (WIHS) IV, Chicago Consortium
$3,025,528Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2011 · AI
Targeted Bone Regeneration via Activation of Resident Stem Cells
$3,025,490Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR
COG NCTN Network Group Operations Center
$3,025,319Peter C Adamson · Children'S Hosp Of Philadelphia · U10 · FY2016 · CA
Cancer Center Support Grant
$3,025,267Steven K. Libutti · Rbhs -Cancer Institute Of New Jersey · P30 · FY2022 · CA
Cancer Center Support Grant
$3,025,267Steven K. Libutti · Rutgers Biomedical And Health Sciences · P30 · FY2023 · CA
Cancer Center Support Grant
$3,025,267Steven K. Libutti · Rbhs -Cancer Institute Of New Jersey · P30 · FY2021 · CA
SPORE IN BREAST CANCER
$3,025,161University Of Alabama At Birmingham · P50 · FY2003 · CA
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
$3,024,895E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2020 · CA
Cross Sectional and Longitudinal Racial Disparity in Molecular Biomarkers of Alzheimer Disease
$3,024,874Chengjie Xiong · Washington University · R01 · FY2020 · AG
NIAID Vaccine Immune T cell and Antibody Laboratory Core
$3,024,370Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIC · FY2014 · AI
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder.
$3,024,162Ian Gurrell · Astrazeneca Pharmaceuticals, Lp · UH3 · FY2024 · DA
Evaluating Modes of Influenza Transmission (EMIT-2) using Innovative Technologies and Designs in Controlled Environments
$3,024,086Donald K Milton · Univ Of Maryland, College Park · U19 · FY2021 · AI
Action for the Control of Cardiovascular Risks in Diabetes (ACCORD)
$3,023,152National Heart, Lung, And Blood Institute · Y01 · FY2009 · HL
SPORE in Breast Cancer
$3,022,773University Of North Carolina Chapel Hill · P50 · FY2003 · CA
REGULATORY MANAGEMENT CENTER
$3,022,265Charity-Anne Schuller · Ppd Development Lp · N01 · FY2020 · AI
NRG Oncology Network Group Operations Center
$3,022,076Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2022 · CA
North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing 2
$3,021,823Jonathan S Berg · Univ Of North Carolina Chapel Hill · U01 · FY2017 · HG
Moffitt Cancer Center Support Grant
$3,021,607William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2009 · CA